Lombard Odier Asset Management (USA)’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-31,250
Closed -$328K 184
2017
Q2
$328K Buy
+31,250
New +$328K 0.03% 159